Company Filing History:
Years Active: 2019
Title: Discovering Innovations in Acetylcholine Receptors: The Journey of Inventor Thierry Vermat
Introduction
Thierry Vermat, an accomplished inventor based in Chazay d'Azergues, France, has made significant contributions to the field of molecular biology through his innovative work on mammalian cell lines. His research focuses on the expression of functional nematode acetylcholine receptors, which plays a crucial role in developing high-throughput screening assays for new parasiticidal compounds.
Latest Patents
One of Vermat's notable patents is titled "Mammalian cell lines expressing functional nematode acetylcholine receptors and use thereof for high-throughput screening assays." This patent discloses the creation of mammalian cell lines that stably express functional nematode acetylcholine receptor subunits. The remarkable advancement made possible by the stable co-expression of the chaperone protein, RIC3, enables these cell lines to express functional ion channels. This innovation is instrumental for high throughput screening (HTS) of compounds aimed at identifying new candidate active ingredients, particularly nematocidal and parasiticidal substances.
Career Highlights
Throughout his career, Thierry Vermat has worked with prominent companies in the pharmaceutical and animal health sectors. Notably, he has held positions at Boehringer Ingelheim Animal Health, Inc., and Sanofi. These experiences have contributed to his deep understanding of biopharmaceutical development and the application of genetic engineering techniques.
Collaborations
Vermat worked alongside talented colleagues such as Lance Hammerland and Brenda Bondesen, which has further enhanced his innovative efforts in the research and development of cell lines for drug discovery. The teamwork and synergy in these collaborations have resulted in groundbreaking advancements in the study of acetylcholine receptors.
Conclusion
Inventor Thierry Vermat's work with mammalian cell lines and its applications in high-throughput screening represents a significant milestone in the field of drug discovery. His contributions have the potential to shape the future of parasitic treatments and highlight the importance of innovative research in improving health outcomes. As the landscape of biotechnology continues to evolve, the impact of Vermat's inventions will be felt for years to come.